TradingView
RocketTickers
Aug 16, 2018 4:57 PM

Regeneron and Teva Announce Positive Topline Phase 3 Long

NASDAQ:REGN1D
Regeneron Pharmaceuticals, Inc.NASDAQ

Description

⋅
TEVA: Teva Pharmaceutical Industries Ltd.
2018-08-16 07:00:00
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Beyond Technical Analysis
More